TREC: Transanal endoscopic microsurgery (TEM) and Radiotherapy in Early rectal Cancer: a randomised phase II feasibility study

Trial Overview

AcronymTREC
NumberISRCTN14422743
Protocol Linkhttp://www.birmingham.ac.uk/Documents/college-mds/trials/bctu/trec/TREC-protocol-v1.pdf
Public Trial Registry Linkhttp://www.isrctn.com/ISRCTN14422743
StatusClosed
CategoryColorectal Cancer - Rectal Specific
Treatment CourseNeoadjuvant

Trial Description

TREC will determine the feasibility of performing a randomised controlled trial (RCT) of radical total mesorectal excision (TME) surgery (current gold standard) versus short course pre-operative radiotherapy (SCPRT) and delayed local excision at 8 - 10 weeks for T1-2N0M0 rectal cancer defined according to both magnetic resonance imaging (MRI) and endorectal ultrasound (ERUS).

Chief Investigator

Simon Bach
Mr
Profile Link

Lead Centre

University of Birmingham
Birmingham B15 2TT
Birmingham
B15 2TT
UK
Website

Collaboration and Funding

Collaborative Sites

Additional Information

Full Research Summary
ESCP Affiliates